GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Current Accrued Expense

Voluntis (XPAR:ALVTX) Current Accrued Expense : €0.00 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Current Accrued Expense?

Voluntis's Current Accrued Expense for the quarter that ended in Jun. 2021 was €0.00 Mil.


Voluntis Current Accrued Expense Historical Data

The historical data trend for Voluntis's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Current Accrued Expense Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Current Accrued Expense
- - - - -

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voluntis Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Voluntis Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Voluntis's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines